-
Dihydrotestosterone Workflows for AR Signaling
2026-09-05
Dihydrotestosterone (DHT) provides a controlled way to activate androgen receptor signaling and interrogate EGFR, ERBB2, AKT, and ERK responses in bladder cancer models. This practical guide also distinguishes established cancer and ALS applications from exploratory extensions into germ-cell assays, with formulation, workflow, and troubleshooting guidance.
-
Podocyte Exosomal HMGB1 in Lupus Nephritis
2026-09-04
The reference study identifies podocyte-derived exosomal HMGB1 as a mediator of glomerular endothelial cell injury in lupus nephritis and places TRIM27 downstream of this intercellular signal. Its combined human, cellular, pharmacologic, and mouse-model evidence provides a framework for testing whether vesicle-mediated podocyte–endothelial communication contributes to proteinuria and renal inflammation.
-
Cdc42-Targeted Signaling in Kidney Fibrosis
2026-09-04
The reference study identifies the plant-derived daphnepedunin A as an anti-fibrotic lead that acts through Cdc42-mediated control of the PKCζ/GSK-3β/β-catenin axis. Its combination of bioassay-guided chemistry, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a useful framework for evaluating Cdc42 as a kidney-fibrosis target.
-
NSC-23766: Translational Control of Rac1
2026-09-03
NSC-23766 offers a mechanistically defined way to interrogate Rac1 activation across cancer, endothelial, intestinal, and stem-cell models. This thought-leadership article connects GEF-level pharmacology with assay strategy, translational biomarker selection, and the emerging biology of Rac-regulated phagocytosis.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-03
TH287 gives cancer researchers a precise way to stress oxidized nucleotide handling before ionizing radiation, with schedule optimization at the center of the workflow. This article translates CRPC findings into practical dosing, DNA-damage assays, troubleshooting steps, and selectivity controls.
-
Cdc42 Targeting in Kidney Fibrosis: Study Insights
2026-09-02
The reference study identifies the natural diterpenoid daphnepedunin A as an anti-fibrotic lead that directly targets Cdc42 and interrupts downstream PKCζ/GSK-3β/β-catenin signaling. Its combination of bioassay-guided discovery, thermal proteome profiling, renal fibroblast experiments, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42-directed strategies in chronic kidney disease.
-
Substance P Workflows for NK-1 Signaling Research
2026-09-02
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with a water-compatible peptide workflow. Learn how spectral preprocessing concepts from bioaerosol research can strengthen assay quality control without overstating cross-domain evidence.
-
GW4064 and the FXR–TLR4–Ferroptosis Axis
2026-09-01
GW4064 is a non-steroidal FXR agonist that connects bile acid and lipid regulation with a mechanistically informative LX-2 fibrosis model. This evidence-focused guide explains how to design, interpret, and troubleshoot FXR activation experiments without confusing pharmacological response with therapeutic proof.
-
Mother–Child iPSC Models of MDD and Bipolar Disorder
2026-09-01
This resource study generated and validated two non-integrating human iPSC lines from a mother with major depressive disorder and her son with bipolar disorder. Their familial relationship provides a useful framework for comparing shared and disorder-specific biology while preserving important genetic, sex, and age-related limitations.
-
Biotinylation Maps the CADASIL Neurovascular Interface
2026-08-31
A mechanistic and translational framework for using Sulfo-NHS-Biotin to connect NOTCH3-driven vascular pathology with cell-surface proteomics, cognitive phenotypes, and decision-grade CADASIL model validation.
-
Capsazepine: From TRPV1 Mechanism to Translation
2026-08-31
Capsazepine offers a target-proximal way to dissect TRPV1-driven nociception while exposing important calcium-channel and TRPM8 liabilities. This thought-leadership guide connects rigorous antagonist validation with multidimensional pain models, apoptosis studies, and translational decision-making.
-
Sodium Nitroprusside in Sex-Aware Vascular Assays
2026-08-30
Sodium Nitroprusside is a nitric oxide donor that can function as a mechanistic probe of vascular smooth muscle reserve, not merely a vasodilator. This guide connects its molecular action with the sex-dependent hypertension findings of Xue et al. and translates them into better-controlled vascular and platelet assays.
-
Oligo (dT) 25 Beads: mRNA Workflow
2026-08-29
Oligo (dT) 25 Beads, SKU K1306, provide a magnetic workflow for enriching polyadenylated eukaryotic mRNA from total RNA or animal and plant samples. They are appropriate for polyA-selected mRNA workflows, but not as a universal cleanup reagent for non-polyadenylated RNA, bacterial RNA, or applications requiring unbiased transcript recovery.
-
DAMGO: From Receptor Probe to Pain-Circuit Assay
2026-08-28
DAMGO is a selective µ-opioid receptor agonist for connecting receptor activation with tissue, cellular, and pain-circuit phenotypes. This guide translates recent circuit-level findings into practical assay-selection, control, and interpretation strategies for opioid receptor signaling research.
-
Urolithin A in Mitochondrial Research Workflows
2026-08-28
Urolithin A offers a practical way to connect mitophagy, respiratory function, and metabolic remodeling in cellular assays. This workflow shows how to test its mitochondrial effects alongside glutamine-metabolism endpoints relevant to hepatic stellate-cell and fibrosis research, while avoiding overinterpretation of cross-domain evidence.